Drug Type Small molecule drug |
Synonyms Omeprazole/Lansoprazole, Secretol |
Target |
Action inhibitors |
Mechanism Proton pump inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H14F3N3O2S |
InChIKeyMJIHNNLFOKEZEW-UHFFFAOYSA-N |
CAS Registry103577-45-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyspepsia | Phase 2 | United States | 01 May 2010 | |
Erosive esophagitis | Phase 2 | United States | 01 May 2010 | |
Gastroesophageal Reflux | Phase 2 | United States | 01 May 2010 | |
Heartburn | Phase 2 | United States | 01 May 2010 | |
Barrett Esophagus | Phase 2 | - | - | |
Ulcer | Phase 2 | - | - | |
Adenocarcinoma of Esophagus | Phase 1 | United States | 01 Apr 2013 |